HST Global Logo   Home | FAQ | News
header people




HST Global is an Integrated Biotechnology Health and Wellness Company that is actively working toward the development and acquisition of Integrative Medical Centers worldwide that are primarily focused on the management and treatment of late stage cancer. In addition, the company plans to acquire novel evidence-based products and technologies for the supportive care of late stage cancer. In this regard, the company focuses on immunotherapeutic and alternative product candidates that are undergoing or have completed significant clinical testing for the adjunct treatment of late stage cancer. 


Research and Development: Background

Today the majority of cancer patients opt to complement conventional treatments with alternative and integrative therapies that may not only temper the adverse side effects of conventional cancer therapy, but also may improve its effectiveness via significant, clinically validated independent anti-cancer effects.

Complementary Alternative Medical Therapies (CAM) is a collective term for an array of remedies that lie outside what is traditionally considered conventional medical treatment for cancer. The use of CAM is now vastly popular among cancer patients undergoing conventional treatment with over 72 million patients actively seeking and utilizing CAM therapies annually to help control and improve the outcomes of their disease. In the United States for example, 91 percent of cancer patients now actively seek to implement CAM in addition to undergoing conventional cancer treatment.

An integrative approach to cancer care utilizing CAM requires significant physician directed lifestyle modification, nutrition and supplementation, neurologic and therapeutic movement, and mind-body interventions to maximize the efficacy and minimize the side effects of treatment. As growing scientific peer-reviewed evidence supports the validity of integrative therapies, more cancer specialists and integrative physicians around the world are recommending and embracing integrative treatment strategies.

HST Center’s for Integrative Cancer Treatment (“FIT” Wellness Centers) seek to be the world leader in comprehensive cancer treatment, combining conventional oncology modalities with integrative and complementary (CAM) therapies to help patients successfully conquer cancer and achieve lifelong wellness. 

The New Frontier: Nutraceutical and Medical Food Platforms

HST Global recognizes the market for nutraceutical products has been flourishing in recent years and promises a robust growth outlook. According to the latest analysis from Frost and Sullivan,1 growing consumer awareness of nutraceutical benefits coupled with the escalating costs of healthcare are among the key factors shaping this market in North America. This report predicts that the nutraceutical industry in North America is set to "grow consistently." Chief among the factors to consider are the large Baby Boomer population, a population that can be characterized by relative affluence and a keen interest in preventive healthcare.1

With the North American Baby Boomer population standing at 80 million, one out of every three Americans will be age 50 or over by 2010 (the term “Baby-Boomer” typically refers to the generation born roughly between the years 1946 and 1964). These facts, in conjunction with continued advances in age and condition-specific products and technologies bode well for the industry as a whole. There is an especially robust market for nutraceutical products particularly among these older consumers. For example, Nutraceutical Market Research published by the Freedonia Group states that the North American anti-aging product industry is currently $20 billion strong and expected to grow by 8.7 percent annually through 2009.2

HST plans to mature the expansion and development of two unique product lines:

  • Physician-formulated nutritional products designed to provide nutritional support for cancer patients and therapies as well as address wellness challenges, and provide nutritional support for preventative maintenance and overall health.
  • A Medical Food Line* providing new and novel physician-based therapeutic approaches that positively impact patients with cancer, immune, and degenerative disorders, who are in need of effective, well-tolerated treatments.

* Through a proprietary scientific platform, HST is planning for the development of therapies that address metabolic deficiencies through the application of Medical Foods (FDA-regulated products, in a relatively new category of medical protocols defined by Congress as part of the Orphan Drug Act).

Medical Foods are formulated to be consumed or administered under the direct supervision of a physician and are intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation. Medical Foods can be prescription products, but are different than drugs or dietary supplements (also called nutritional supplements or nutraceuticals) in several aspects, such as their claims. Claims for both Medical Foods and drugs must be supported by solid laboratory and clinical data.

HST’s robust approach to integrative cancer supportive care is intended to provide the best of conventional and integrative therapies and thus, equip patients with a “survivor’s edge” by enhancing quality of life and improving patient outcomes. This approach charts an exciting new future for comprehensive cancer treatment around the world as HST “FIT” Center rehabilitation programs are designed to enable patients to regain and ultimately rebuild their resilience – adding life to years.  


Copyright © 2010 HST Global - Adding Life to your Years.